Dr. Alexandros Marios Sofias, RWTH Aachen University, Germany
The Institute for Experimental Molecular Imaging’s (RWTH Aachen) research team uses MILabs Optical imaging system, intravital microscopy, and immunohistochemistry to investigate cancer nanomedicine delivery and uptake in vivo. The webinar focuses on how they use CT-guided fluorescent tomography (FLT/CT) and what they can get out of it.
Took place: EMIM, August 2021
You may also like
This webinar describes Miltenyi Biotech’s approach establishing multimodal optical imaging of CAR T cell therapies, using the MILabs optical imaging micro CT system.
This webinar covers some recent groundbreaking studies conducted by the Cornelissen group in Oxford. Several recent papers will be presented including ‘Early detection in a mouse model of pancreatic cancer by imaging DNA damage response signaling’, ‘Dual-isotope antibody imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours’, and ‘Imaging DNA Damage Repair in vivo Following 177Lu-DOTATATE Therapy’.
Marko Rosenholm presents some of the findings and results regarding dynamic SPECT/CT imaging of a glymphatic system they have acquired with the MILabs VECTor/CT system.
